EP
ULBI icon

Essential Partners’s Ultralife ULBI Stock Holding History

Essential Partners’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$9 – 2792
2025
Q2 		$9 Buy
+1
New +$6 ﹤0.01% 2255

Other funds holding ULBI

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.53B AUM 24.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
THC
Truffle Hound Capital Bethesda, Maryland $468M AUM 42.57% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Essential Partners's ULBI Position: Q3 2025 in Review

Essential Partners sold out of Ultralife (ULBI) in Q3 2025, closing a stake of 1 share — an estimated $9 sold.

Essential Partners first reported a position in ULBI in Q2 2025 and held it in 1 quarter. The position peaked at $9 in Q2 2025. 63 funds tracked by Wall St. Rank hold ULBI as of Q3 2025.

  • Essential Partners reported no remaining Ultralife position as of Q3 2025 after selling out during the quarter.
  • Essential Partners sold 1 Ultralife share in Q3 2025, an estimated $9.
  • Essential Partners first reported a position in Ultralife in Q2 2025 and held it in 1 quarter.
  • Essential Partners's Ultralife position peaked at $9 in Q2 2025.
  • 63 funds tracked by Wall St. Rank held Ultralife as of Q3 2025.

Based on Essential Partners's 13F filing for Q3 2025, filed 21 May 2026.